A Phase2 of A-101 Topical Solution in Subjects With Common Warts

NCT03210337 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
157
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aclaris Therapeutics, Inc.